2018
DOI: 10.4103/jpp.jpp_41_18
|View full text |Cite
|
Sign up to set email alerts
|

Adverse Drug Reactions at an Addiction Psychiatry Center: A Cross-sectional Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
(19 reference statements)
0
1
0
Order By: Relevance
“…[ 2 3 4 ] Nausea, drowsiness, abdominal pain, and diarrhea were common adverse effects, whereas psychiatric (psychotic features, catatonia, and altered consciousness) and neurological complications (convulsions) were reported to be the most important. [ 3 4 5 ] Our center routinely prescribes supervised disulfiram to patients with alcohol use disorders, number of patients ranging from 30 to more than 50/month. Considering the need for renewed research on adverse effects associated with disulfiram and the paucity of data-based studies on the topic, we sought to assess ADRs reported by patients who received disulfiram for the treatment of alcohol use disorders using a prescription-based audit spanning over 15 months from January 1, 2019, to March 31, 2020, during which approximately 614 patients were prescribed disulfiram.…”
mentioning
confidence: 99%
“…[ 2 3 4 ] Nausea, drowsiness, abdominal pain, and diarrhea were common adverse effects, whereas psychiatric (psychotic features, catatonia, and altered consciousness) and neurological complications (convulsions) were reported to be the most important. [ 3 4 5 ] Our center routinely prescribes supervised disulfiram to patients with alcohol use disorders, number of patients ranging from 30 to more than 50/month. Considering the need for renewed research on adverse effects associated with disulfiram and the paucity of data-based studies on the topic, we sought to assess ADRs reported by patients who received disulfiram for the treatment of alcohol use disorders using a prescription-based audit spanning over 15 months from January 1, 2019, to March 31, 2020, during which approximately 614 patients were prescribed disulfiram.…”
mentioning
confidence: 99%